What is Salus Bioscience?
Salus Bioscience operates as a critical provider of laboratory water purification systems, addressing the rigorous demands of modern research facilities. By offering a comprehensive suite of products, including high-performance replacement consumables for Millipore Water Systems and advanced filtration technologies, the company ensures that laboratories maintain the precise water quality necessary for reproducible scientific outcomes. Their market position is defined by a commitment to operational reliability and technical excellence, serving as an essential partner for institutions that prioritize accuracy in their experimental workflows. Through its focus on high-quality purification solutions, Salus Bioscience has carved out a niche as a vital supplier in the life sciences and analytical research supply chain.
How much funding has Salus Bioscience raised?
Salus Bioscience has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
Key Investors in Salus Bioscience
PPP
Public-Private Partnership
What's next for Salus Bioscience?
With the infusion of $20K, Salus Bioscience is poised to accelerate its strategic growth initiatives. The company is expected to leverage this financing to broaden its product portfolio and enhance its distribution capabilities, ensuring that its purification systems reach a wider array of research institutions. As the firm transitions through this significant Series B/C stage, management will likely prioritize operational scaling and the optimization of its supply chain to meet the increasing demand for high-purity laboratory water. By reinforcing its market presence and investing in innovation, Salus Bioscience aims to solidify its reputation as a cornerstone provider for the global scientific community, ultimately driving long-term value for its stakeholders and supporting the advancement of critical research.
See full Salus Bioscience company page
